ArticleJournal of clinical medicine2022

PD-L1-Positive High-Grade Triple-Negative Breast Cancer Patients Respond Better to Standard Neoadjuvant Treatment-A Retrospective Study of PD-L1 Expression in Relation to Different Clinicopathological Parameters.

Olga Stanowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.